These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24372954)

  • 1. Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States.
    Barratt MJ; Ferris JA; Winstock AR
    Addiction; 2014 May; 109(5):774-83. PubMed ID: 24372954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
    Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
    Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Surfing the Silk Road': a study of users' experiences.
    Van Hout MC; Bingham T
    Int J Drug Policy; 2013 Nov; 24(6):524-9. PubMed ID: 24075939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
    Barratt MJ; Lenton S; Maddox A; Allen M
    Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Silk Road', the virtual drug marketplace: a single case study of user experiences.
    Van Hout MC; Bingham T
    Int J Drug Policy; 2013 Sep; 24(5):385-91. PubMed ID: 23465646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
    van der Gouwe D; Brunt TM; van Laar M; van der Pol P
    Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating drug trafficking on the Tor Network: Silk Road 2, the sequel.
    Dolliver DS
    Int J Drug Policy; 2015 Nov; 26(11):1113-23. PubMed ID: 25681266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on Barratt et al. (2014): Steps towards characterizing online anonymous drug marketplace customers.
    Christin N
    Addiction; 2014 May; 109(5):784-5. PubMed ID: 24720826
    [No Abstract]   [Full Text] [Related]  

  • 12. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey.
    van der Sanden R; Wilkins C; Romeo JS; Rychert M; Barratt MJ
    Int J Drug Policy; 2021 Dec; 98():103430. PubMed ID: 34487954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysubstance use, mental health and high-risk behaviours: Results from the 2012 Global Drug Survey.
    Morley KI; Lynskey MT; Moran P; Borschmann R; Winstock AR
    Drug Alcohol Rev; 2015 Jul; 34(4):427-37. PubMed ID: 25867685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study.
    Coney L; Peacock A; Malm A; Munksgaard R; Aldridge J; Ferris JA; Maier LJ; Winstock AR; Barratt MJ
    Int J Drug Policy; 2024 Jan; 123():104258. PubMed ID: 38056221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
    Wilkins C; Romeo JS; Rychert M; Prasad J; Graydon-Guy T
    Int J Drug Policy; 2018 Nov; 61():15-22. PubMed ID: 30347325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global patterns of domestic cannabis cultivation: sample characteristics and patterns of growing across eleven countries.
    Potter GR; Barratt MJ; Malm A; Bouchard M; Blok T; Christensen AS; Decorte T; Frank VA; Hakkarainen P; Klein A; Lenton S; Perälä J; Werse B; Wouters M
    Int J Drug Policy; 2015 Mar; 26(3):226-37. PubMed ID: 25582281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.